JP2004536801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536801A5 JP2004536801A5 JP2002588990A JP2002588990A JP2004536801A5 JP 2004536801 A5 JP2004536801 A5 JP 2004536801A5 JP 2002588990 A JP2002588990 A JP 2002588990A JP 2002588990 A JP2002588990 A JP 2002588990A JP 2004536801 A5 JP2004536801 A5 JP 2004536801A5
- Authority
- JP
- Japan
- Prior art keywords
- gla
- sda
- rich
- polar lipids
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002632 lipids Chemical class 0.000 description 42
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 34
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 34
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 30
- 229960002733 gamolenic acid Drugs 0.000 description 23
- 238000000034 method Methods 0.000 description 23
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 22
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 22
- 150000003904 phospholipids Chemical group 0.000 description 18
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 244000005700 microbiome Species 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 240000006240 Linum usitatissimum Species 0.000 description 5
- 235000004431 Linum usitatissimum Nutrition 0.000 description 5
- 235000004426 flaxseed Nutrition 0.000 description 5
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 244000105624 Arachis hypogaea Species 0.000 description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 3
- 240000002791 Brassica napus Species 0.000 description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 3
- 244000188595 Brassica sinapistrum Species 0.000 description 3
- 244000020518 Carthamus tinctorius Species 0.000 description 3
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000020551 Helianthus annuus Species 0.000 description 3
- 235000003222 Helianthus annuus Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 206010025476 Malabsorption Diseases 0.000 description 2
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004968 inflammatory condition Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 125000005457 triglyceride group Chemical group 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- -1 GLA and SDA Chemical class 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 150000002066 eicosanoids Chemical class 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000003203 triacylglycerol group Chemical group 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29148401P | 2001-05-14 | 2001-05-14 | |
| US60/291,484 | 2001-05-14 | ||
| PCT/US2002/015479 WO2002092073A1 (en) | 2001-05-14 | 2002-05-14 | Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010127566A Division JP2010229144A (ja) | 2001-05-14 | 2010-06-03 | 植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004536801A JP2004536801A (ja) | 2004-12-09 |
| JP2004536801A5 true JP2004536801A5 (cg-RX-API-DMAC7.html) | 2009-04-16 |
| JP4728561B2 JP4728561B2 (ja) | 2011-07-20 |
Family
ID=23120484
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002588990A Expired - Fee Related JP4728561B2 (ja) | 2001-05-14 | 2002-05-14 | 植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法 |
| JP2010127566A Ceased JP2010229144A (ja) | 2001-05-14 | 2010-06-03 | 植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010127566A Ceased JP2010229144A (ja) | 2001-05-14 | 2010-06-03 | 植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070004678A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2275101A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4728561B2 (cg-RX-API-DMAC7.html) |
| AU (3) | AU2002318135B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2446059C (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03010467A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002092073A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002309856B2 (en) * | 2001-05-14 | 2008-10-23 | Dsm Ip Assets B.V. | Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| JP4499371B2 (ja) * | 2003-01-14 | 2010-07-07 | 株式会社 エフェクト | 落花生由来のプロアントシアニジンの製造方法 |
| JP4541662B2 (ja) * | 2003-05-29 | 2010-09-08 | オリザ油化株式会社 | 抗ピロリ菌組成物 |
| DK1656449T3 (da) | 2003-08-21 | 2009-06-02 | Monsanto Technology Llc | Fedtsyredesaturaser fra primula |
| JP4313632B2 (ja) * | 2003-09-05 | 2009-08-12 | ポーラ化成工業株式会社 | 食品組成物 |
| MY140210A (en) * | 2003-12-22 | 2009-11-30 | Suntory Holdings Ltd | Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same |
| EP2902021B1 (en) | 2004-04-16 | 2018-11-14 | Monsanto Technology LLC | Expression of fatty acid desaturases in corn |
| US20050266051A1 (en) * | 2004-05-27 | 2005-12-01 | The Procter & Gamble Company | Pet food compositions and methods |
| PL1809118T3 (pl) | 2004-11-04 | 2017-07-31 | Monsanto Technology Llc | Kompozycje oleju z nasion |
| EP1965658B2 (en) | 2005-11-18 | 2022-10-05 | Commonwealth Scientific and Industrial Research Organisation | Feedstuffs for aquaculture comprising stearidonic acid feedstuffs for aquaculture |
| CA2645148C (en) | 2006-03-10 | 2018-05-22 | Monsanto Technology Llc | Soybean seed and oil compositions and methods of making same |
| EP2041275B1 (en) * | 2006-07-19 | 2011-05-04 | Monsanto Technology, LLC | Fatty acid desaturases from tetraselmis suecica |
| EP2117335A4 (en) | 2007-01-03 | 2013-05-01 | Monsanto Technology Llc | FOOD COMPOSITIONS WITH STEARIDONIC ACID |
| US10045951B2 (en) * | 2007-05-25 | 2018-08-14 | The Trustees Of The University Of Pennsylvania | Flaxseed lignan complex and its use thereof |
| US10449224B2 (en) | 2007-05-25 | 2019-10-22 | The Trustees Of The University Of Pennsylvania | Flaxseed lignan complex, methods of using and compositions thereof |
| NZ583662A (en) * | 2007-08-17 | 2012-04-27 | Murray Goulburn Coop Co Ltd | Compositions comprising phospholipids |
| KR20160052805A (ko) | 2007-09-12 | 2016-05-12 | 디에스엠 아이피 어셋츠 비.브이. | 생물학적 오일 및 이의 생산 및 용도 |
| CA2704371A1 (en) * | 2007-11-01 | 2009-05-07 | Wake Forest University School Of Medicine | Compositions and methods for prevention and treatment of mammalian diseases |
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| US20100291267A1 (en) * | 2007-11-29 | 2010-11-18 | Monsanto Technology Llc | Meat products with increased levels of beneficial fatty acids |
| AR070320A1 (es) * | 2008-01-29 | 2010-03-31 | Monsanto Technology Llc | Metodos para alimentar cerdos y productos que comprenden acidos grasos beneficos |
| US20090197955A1 (en) * | 2008-01-31 | 2009-08-06 | Monsanto Company | Methods of improving dha deposition and related function and/or development |
| WO2009102558A2 (en) * | 2008-02-11 | 2009-08-20 | Monsanto Technology Llc | Aquaculture feed, products, and methods comprising beneficial fatty acids |
| US20110237851A1 (en) * | 2008-04-25 | 2011-09-29 | Conocophillips Company | Thermal cracking of impurities in triglyceride feedstock |
| GB0814105D0 (en) * | 2008-08-01 | 2008-09-10 | Springdale Sustainable Develop | Composition for accelerated production of collagen |
| US8501422B2 (en) | 2008-09-25 | 2013-08-06 | F. Hoffman-La Roche SA | Methods of detecting and treating pulmonary disease and markers thereof |
| JP2010079993A (ja) * | 2008-09-26 | 2010-04-08 | Toshiba Storage Device Corp | 記憶装置および記憶装置の調整方法 |
| CA2751275A1 (en) | 2009-02-02 | 2010-08-05 | Martek Biosciences Corporation | Use of docosahexaenoic acid in treating mild cognitive impairment |
| GB0902040D0 (en) | 2009-02-06 | 2009-03-11 | Seeds Lp | Composition for treatment of skin |
| US8323708B2 (en) * | 2009-03-16 | 2012-12-04 | Monsanto Technology Llc | Poultry meat and eggs comprising beneficial fatty acids |
| CA2755438C (en) * | 2009-03-16 | 2016-10-11 | Monsanto Technology Llc | Poultry meat and eggs comprising beneficial fatty acids |
| EP2272383A1 (en) | 2009-06-22 | 2011-01-12 | SBAE Industries NV | Composition Comprising Omega-7 and/or Omega-4 Fatty Acids |
| BRPI1015920B1 (pt) * | 2009-06-30 | 2019-06-18 | Monsanto Technology Llc | Formulação de manteiga de noz ou formulação spread de manteiga de noz e seu método de preparo |
| US20110177061A1 (en) | 2009-07-10 | 2011-07-21 | Martek Biosciences Corporation | Methods of treating and preventing neurological disorders using docosahexaenoic acid |
| US9480271B2 (en) | 2009-09-15 | 2016-11-01 | Monsanto Technology Llc | Soybean seed and oil compositions and methods of making same |
| WO2011041710A2 (en) | 2009-10-01 | 2011-04-07 | Martek Biosciences Corporation | Docosahexaenoic acid gel caps |
| SG185578A1 (en) | 2010-06-14 | 2013-01-30 | Io Mega Holding Corp | Methods for the production of algae derived oils |
| US8563611B2 (en) * | 2011-03-17 | 2013-10-22 | Women's & Children's Health Research Institute | Methods and compositions for promoting the respiratory development of an infant |
| WO2013024174A1 (en) | 2011-08-18 | 2013-02-21 | Dsm Ip Assets B.V. | Dha triglyceride, dha free fatty acid, and dha ethyl ester emulsions, and methods of treating spinal cord injury |
| KR20220059969A (ko) | 2011-11-01 | 2022-05-10 | 디에스엠 아이피 어셋츠 비.브이. | 산화적으로 안정한 다중불포화된 지방산 함유 오일 |
| KR101589825B1 (ko) * | 2014-03-25 | 2016-02-01 | 고려대학교 산학협력단 | 에키움 오일로부터 농축된 스테아리돈산을 회수하는 방법 |
| CN106302571B (zh) * | 2015-05-14 | 2020-07-28 | 微软技术许可有限责任公司 | 用于对服务器连接进行维护和高速缓存的系统和方法 |
| JP6885582B2 (ja) * | 2017-02-23 | 2021-06-16 | 御木本製薬株式会社 | トランスグルタミナーゼ活性促進剤 |
| CN115569093B (zh) * | 2022-09-09 | 2023-10-13 | 安徽亿人安股份有限公司 | 一种具有抗菌作用的婴儿祛湿护肤膏及其制备方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2490631A1 (fr) * | 1980-09-24 | 1982-03-26 | Roussel Uclaf | Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique |
| GB8408974D0 (en) * | 1984-04-06 | 1984-05-16 | Efamol Ltd | Food production |
| CH663951A5 (fr) * | 1984-10-10 | 1988-01-29 | Nestle Sa | Procede d'enrichissement selectif en acides gras polyinsatures d'un melange contenant des acides gras fractions enrichies obtenues et compositions les contenant. |
| DE3587044T2 (de) * | 1985-01-22 | 1993-06-03 | Japan As Represented By Direct | Verfahren zur herstellung von lipiden aus fungusmassen. |
| GB8507058D0 (en) * | 1985-03-19 | 1985-04-24 | Efamol Ltd | Pharmaceutical & dietary compositions |
| GB8621816D0 (en) * | 1986-09-10 | 1986-10-15 | Efamol Ltd | Therapeutic composition |
| US4816271A (en) * | 1987-01-16 | 1989-03-28 | Adelia Scaffidi | Skin lotions and creams |
| GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
| EP0457950B1 (fr) * | 1990-05-23 | 1993-10-20 | Societe Des Produits Nestle S.A. | Utilisation de l'acide stéaridonique pour le traitement des maladies inflammatoires |
| GB9012651D0 (en) * | 1990-06-06 | 1990-07-25 | Efamol Holdings | Essential fatty acid treatment |
| PH31293A (en) * | 1991-10-10 | 1998-07-06 | Rhone Poulenc Agrochimie | Production of y-linolenic acid by a delta6-desaturage. |
| DE4219360C2 (de) * | 1992-06-12 | 1994-07-28 | Milupa Ag | Verfahren zur Gewinnung von Lipiden mit einem hohen Anteil von langkettig-hochungesättigten Fettsäuren |
| GB9217781D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
| EP0585058A1 (en) * | 1992-08-25 | 1994-03-02 | Scotia Holdings Plc | Pharmaceutical compositions containing fatty acids and heparin |
| GB9423625D0 (en) * | 1994-11-23 | 1995-01-11 | Scotia Holdings Plc | Fortified fruit juice |
| US5583019A (en) * | 1995-01-24 | 1996-12-10 | Omegatech Inc. | Method for production of arachidonic acid |
| US6582941B1 (en) * | 1995-04-17 | 2003-06-24 | Japan As Represented By Director-General Of Agency Of Industrial Science And Technology | Microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms |
| SE504664C2 (sv) * | 1995-09-22 | 1997-03-24 | Scotia Lipidteknik Ab | Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan |
| US5883273A (en) * | 1996-01-26 | 1999-03-16 | Abbott Laboratories | Polyunsaturated fatty acids and fatty acid esters free of sterols and phosphorus compounds |
| US6080787A (en) * | 1997-02-21 | 2000-06-27 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
| US5968809A (en) * | 1997-04-11 | 1999-10-19 | Abbot Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
| US5993221A (en) * | 1997-05-01 | 1999-11-30 | Beth Israel Deaconess Medical Center, Inc. | Dietary formulation comprising arachidonic acid and methods of use |
| GB9715203D0 (en) * | 1997-07-19 | 1997-09-24 | Piper Edwina M | Composition |
| DE19757414A1 (de) * | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
| US6107334A (en) * | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| AU2002309856B2 (en) * | 2001-05-14 | 2008-10-23 | Dsm Ip Assets B.V. | Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| ES2288193T3 (es) * | 2001-07-27 | 2008-01-01 | NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. | Fosfolipidos naturales de origen marino que contienen flavonoides y fosfolipidos poliinsaturados y sus usos. |
-
2002
- 2002-05-14 WO PCT/US2002/015479 patent/WO2002092073A1/en not_active Ceased
- 2002-05-14 MX MXPA03010467A patent/MXPA03010467A/es active IP Right Grant
- 2002-05-14 JP JP2002588990A patent/JP4728561B2/ja not_active Expired - Fee Related
- 2002-05-14 CA CA2446059A patent/CA2446059C/en not_active Expired - Fee Related
- 2002-05-14 EP EP10176352A patent/EP2275101A1/en not_active Withdrawn
- 2002-05-14 AU AU2002318135A patent/AU2002318135B2/en not_active Ceased
- 2002-05-14 EP EP02747838A patent/EP1392278A4/en not_active Withdrawn
- 2002-05-14 CA CA2689808A patent/CA2689808A1/en not_active Abandoned
- 2002-05-14 US US10/487,169 patent/US20070004678A1/en not_active Abandoned
-
2007
- 2007-10-15 AU AU2007225606A patent/AU2007225606B2/en not_active Ceased
-
2009
- 2009-09-02 AU AU2009212905A patent/AU2009212905A1/en not_active Abandoned
-
2010
- 2010-06-03 JP JP2010127566A patent/JP2010229144A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004536801A5 (cg-RX-API-DMAC7.html) | ||
| JP4728561B2 (ja) | 植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法 | |
| JP2010065048A (ja) | 微生物、遺伝的に改変された植物種子および海洋生物由来のω−３および／またはω−６高度不飽和脂肪酸を含有する極性脂質の豊富な画分の生成および使用 | |
| AU2002318135A1 (en) | Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes | |
| Lim et al. | An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n‐6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance | |
| AU2002309856A1 (en) | Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms | |
| Shahidi | Nutraceutical and specialty lipids | |
| JP2004536059A5 (cg-RX-API-DMAC7.html) | ||
| US20040209953A1 (en) | Glyceride compositions and methods of making and using same | |
| US20060128665A1 (en) | Marine lipid compositions | |
| JP2018518451A (ja) | 最適化された栄養分の脂肪酸組成 | |
| EP2272383A1 (en) | Composition Comprising Omega-7 and/or Omega-4 Fatty Acids | |
| Bowen-Forbes et al. | Fats | |
| Parmentier et al. | Polar lipids: n-3 PUFA carriers for membranes and brain: nutritional interest and emerging processes | |
| JPH0551271B2 (cg-RX-API-DMAC7.html) | ||
| CN109845840A (zh) | 饱和脂肪酸与中长链脂肪酸结构脂质的制备方法 | |
| JP2005206789A (ja) | 新規油脂組成物 | |
| CN113273613A (zh) | sn-2不饱和脂肪酸活性型结构脂组合物及其制备方法与用途 | |
| Morales et al. | Lipids from marine sources | |
| Singh et al. | Dietary fatty Acids: a key requirement for healthy life with special reference to their future prospects | |
| Currie et al. | Assessment of the Relative Absorbability of Orally Dosed Whole Marine Oils and A Standard, Processed 18/12 Omega-3 Oil-Does Nature Know Best? | |
| HK1152893A (en) | Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses | |
| Pokorný et al. | Food lipids | |
| BR112020026074A2 (pt) | composição de lipídio à base de vegetal, composição nutracêutica, produto alimentício para consumo humano ou animal, e, processo para a produção de uma composição de lipídio à base de vegetais | |
| BR112020026087A2 (pt) | composição de lipídio à base de vegetais, tinta ou verniz, e, processo para produzir uma composição de lipídio |